Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Prostate. 2008 Sep 15;68(13):1467–1476. doi: 10.1002/pros.20812

Table I.

M/E ratio assessed by mRNA ISH and grouped by Gleason score and Reviewer.

MMP/E-cad Ratio
Reviewer GS N Peripheral P-value Central P-value
1 6 7 2.09 (1.09)
(0.96, 3.73)
2.63 (1.27)
(0.95, 4.76)
7 16 3.62 (2.20)
(0.86, 9.83)
2.30 (0.92)
(0.94, 3.99)
8 8 7.04 (4.69)
(0.77, 15.98)
2.44 (1.08)
(0.59, 3.98)
9 5 6.39 (2.54)
(3.25, 9.04)

0.02
3.78 (3.34)
(1.11, 9.36)

0.88
2 6 7 1.56 (0.49)
(0.75, 2.20)
1.21 (0.47)
(0.49, 1.84)
7 16 2.24 (1.33)
(0.74, 5.32)
1.37 (0.46)
(0.61, 2.38)
8 8 5.16 (3.47)
(2.38, 13.22)
2.64 (1.57)
(1.22, 6.14)
9 5 3.46 (0.61)
(2.61, 4.25)

0.0008
1.42 (0.58)
(0.91, 2.35)

0.02

Results represent the mean (SD) of the maximum values for each tumor and the range. M/E, matrix metalloproteinase to E-cadherin; ISH, in situ hybridization; GS, Gleason score; N, number.